Status | Study |
Recruiting |
Study Name: A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome Condition: Barth Syndrome Date: 2017-03-21 Interventions: Drug: Elamipretide 40 mg daily subcutaneous injection for 12 weeks |
Recruiting |
Study Name: North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) Condition: Mitochondrial Disorders Mitochondrial Genetic Disorders Mi Date: 2012-09-25 |
Recruiting |
Study Name: Resistance Exercise in Barth Syndrome Condition: Barth Syndrome Date: 2012-06-20 Interventions: Behavioral: Resistance exercise and protein supplementation Resistance exercise training will occur 3x/w |
Recruiting |
Study Name: Heart and Muscle Metabolism in Barth Syndrome Condition: Barth Syndrome Date: 2012-06-19 |
Available |
Study Name: Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism Condition: Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency Carnitine Palmitoyltransferase Defi Date: 2011-10-25 Interventions: Drug: triheptanoin subjects will receive a modified diet containing triheptanoin (up to 2 grams/kg/24 ho |
Completed |
Study Name: Exercise Training in Barth Syndrome Condition: Barth Syndrome Date: 2010-08-30 Interventions: Behavioral: Exercise training aerobic exercise training, 45-60 minutes, 3x/week, 12 weeks (3-months) |